ImmunityBio Announces ANKTIVA® Is Now Available in Saudi Arabia for Bladder and Lung Cancer Patients; Market Entry Achieved Within Two Months of MENA Partnership
Go back to ImmunityBio Announces ANKTIVA® Is Now Available in Saudi Arabia for Bladder and Lung Cancer Patients; Market Entry Achieved Within Two Months of MENA Partnership| (NASDAQ: IBRX) | Delayed: 7.24 -0.12 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.36 | 52 Week High | $ | |||
| Open | $7.49 | 52 Week Low | $ | |||
| Day High | $7.55 | P/E | N/A | |||
| Day Low | $7.17 | EPS | $ | |||
| Volume | 5,269,569 | |||||
